Staidson Beijing BioPharmaceuticals Co Ltd
SZSE:300204
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Staidson Beijing BioPharmaceuticals Co Ltd
SZSE:300204
|
CN |
Staidson Beijing BioPharmaceuticals Co Ltd
Staidson (Beijing) Biopharmaceuticals Co., Ltd. engages in the research and development, production, and marketing of innovative drugs with independent intellectual property rights. The company is headquartered in Beijing, Beijing and currently employs 873 full-time employees. The company went IPO on 2011-04-15. The Company’s products include mouse nerve growth factor for injection, which are applied in the neuroprotection and treatment of nerve injuries, as well as polyethylene glycol electrolyte powders, which are applied in the bowel cleansing and treatment of constipation. The firm mainly distributes its products in domestic market.
Staidson (Beijing) Biopharmaceuticals Co., Ltd. engages in the research and development, production, and marketing of innovative drugs with independent intellectual property rights. The company is headquartered in Beijing, Beijing and currently employs 873 full-time employees. The company went IPO on 2011-04-15. The Company’s products include mouse nerve growth factor for injection, which are applied in the neuroprotection and treatment of nerve injuries, as well as polyethylene glycol electrolyte powders, which are applied in the bowel cleansing and treatment of constipation. The firm mainly distributes its products in domestic market.
